1. Home
  2. PSN vs MDGL Comparison

PSN vs MDGL Comparison

Compare PSN & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSN
  • MDGL
  • Stock Information
  • Founded
  • PSN 1944
  • MDGL 2011
  • Country
  • PSN United States
  • MDGL United States
  • Employees
  • PSN N/A
  • MDGL N/A
  • Industry
  • PSN EDP Services
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSN Technology
  • MDGL Health Care
  • Exchange
  • PSN Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • PSN 7.8B
  • MDGL 7.1B
  • IPO Year
  • PSN 2019
  • MDGL N/A
  • Fundamental
  • Price
  • PSN $59.40
  • MDGL $336.23
  • Analyst Decision
  • PSN Strong Buy
  • MDGL Buy
  • Analyst Count
  • PSN 12
  • MDGL 14
  • Target Price
  • PSN $97.50
  • MDGL $351.67
  • AVG Volume (30 Days)
  • PSN 1.8M
  • MDGL 347.1K
  • Earning Date
  • PSN 02-19-2025
  • MDGL 02-26-2025
  • Dividend Yield
  • PSN N/A
  • MDGL N/A
  • EPS Growth
  • PSN 49.38
  • MDGL N/A
  • EPS
  • PSN 2.12
  • MDGL N/A
  • Revenue
  • PSN $6,750,576,000.00
  • MDGL $76,813,000.00
  • Revenue This Year
  • PSN $25.71
  • MDGL N/A
  • Revenue Next Year
  • PSN $8.83
  • MDGL $195.95
  • P/E Ratio
  • PSN $28.04
  • MDGL N/A
  • Revenue Growth
  • PSN 24.03
  • MDGL N/A
  • 52 Week Low
  • PSN $57.86
  • MDGL $189.00
  • 52 Week High
  • PSN $114.68
  • MDGL $368.29
  • Technical
  • Relative Strength Index (RSI)
  • PSN 10.86
  • MDGL 52.41
  • Support Level
  • PSN $72.12
  • MDGL $334.13
  • Resistance Level
  • PSN $76.21
  • MDGL $354.49
  • Average True Range (ATR)
  • PSN 2.60
  • MDGL 13.20
  • MACD
  • PSN -1.36
  • MDGL 0.16
  • Stochastic Oscillator
  • PSN 7.17
  • MDGL 43.12

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Share on Social Networks: